Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;26(12):2924-2934.
doi: 10.1007/s12094-024-03561-x. Epub 2024 Jun 12.

The role of IGF/IGF-1R signaling in the regulation of cancer stem cells

Affiliations
Review

The role of IGF/IGF-1R signaling in the regulation of cancer stem cells

Fengchao Liu et al. Clin Transl Oncol. 2024 Dec.

Abstract

Cancer stem cells (CSCs) are a group of tumor cells with high tumorigenic ability and self-renewal potential similar to those of normal stem cells. CSCs are the key "seeds" for tumor development, metastasis, and recurrence. A better insight into the key mechanisms underlying CSC survival improves the efficiency of cancer therapy via specific targeting of CSCs. Insulin-like growth factor (IGF)/IGF-1 receptor (IGF-1R) signaling plays an important role in the maintenance of cancer stemness. However, the effect of IGF/IGF-1R signaling on stemness and CSCs and the underlying mechanisms are still controversial. Based on the similarity between CSCs and normal stem cells, this review discusses emerging data on the functions of IGF/IGF-1R signaling in normal stem cells and CSCs and dissects the underlying mechanisms by which IGF/IGF-1R signaling is involved in CSCs. On the other hand, this review highlighted the role of IGF/IGF-1R signaling blockade in multiple CSCs as a potential strategy to improve CSC-based therapy.

Keywords: 1; 1R; 1R signaling; 2; Cancer stem cells; IGF; IGF/IGF; IGFBPs.

PubMed Disclaimer

Conflict of interest statement

Declarations Conflict of interest The authors declare that there are no competing interests. Consent to publish All authors agree to submit the manuscripts to the journal. Ethical approval (Research involving human participants and/or animals) Not applicable.

Similar articles

Cited by

References

    1. Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24(1):25–40. - PubMed
    1. Lytle NK, Barber AG, Reya T. Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018;18(11):669–80. - PubMed - PMC
    1. Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47–76. - PubMed
    1. Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8. - PubMed - PMC
    1. Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23(10):1124–34. - PubMed

MeSH terms

Substances

LinkOut - more resources